Skip to content
Ravi Tiku’s Perspective: Decoding Today’s Headlines

Ravi Tiku’s Perspective: Decoding Today’s Headlines

The news tells you what happened. We decode why it matters.

  • Home
  • World
  • America
  • Business
  • Technology
  • Health
  • Life
  • Entertainment
  • Ravi’s Perspective

Eli Lilly

Eli Lilly Hits $1 Trillion Market Value With Strong Stock Rally

November 23, 2025
Eli Lilly Hits $1 Trillion Market Value With Strong Stock Rally

Eli Lilly Stock Joins the $1 Trillion Club as LLY Hits New All-Time Highs Eli Lilly became the first U.S. health care company to reach a $1 trillion market value on November 21, 2025. …

Read more

Categories Finance News Tags Eli Lilly, Market cap, Mounjaro, TrumpRx, Zepbound Leave a comment

“Forget Mounjaro: Zepbound is Eli Lilly’s New Blockbuster Taking Over the Weight Loss Market”

August 20, 2024
"Forget Mounjaro: Zepbound is Eli Lilly's New Blockbuster Taking Over the Weight Loss Market"

Forget Mounjaro: Eli Lilly’s Next Big Blockbuster Has Arrived | The Motley Fool Eli Lilly has just introduced its next major blockbuster drug, Zepbound, and it’s making waves in the pharmaceutical industry. On Sunday, …

Read more

Categories Ravi Speaks Tags blockbuster drug, Eli Lilly, Obesity treatment, weight loss drug, Zepbound Leave a comment

“New Study Reveals Tirzepatide’s Impact on Blood Pressure: A Game-Changer for Obesity Management?”

February 7, 2024
"New Study Reveals Tirzepatide's Impact on Blood Pressure: A Game-Changer for Obesity Management?"

The Impact of Tirzepatide on Blood Pressure: A Breakthrough in Obesity and Diabetes Treatment The article discusses a recent study indicating significant reductions in blood pressure among overweight and obese patients taking the diabetes …

Read more

Categories Must See Tags Blood Pressure Reduction, Eli Lilly, Health research, Obesity management, Tirzepatide Leave a comment

“FDA Approves Eli Lilly’s Zepbound: A Game-Changer in Weight Management”

November 9, 2023
"FDA Approves Eli Lilly's Zepbound: A Game-Changer in Weight Management"

FDA approves Eli Lilly’s tirzepatide for weight loss | Fox Business The FDA has granted approval for Eli Lilly’s type 2 diabetes drug, tirzepatide, for use in chronic weight management. This approval formalizes the …

Read more

Categories Must See Tags Eli Lilly, FDA approval, healthcare advancements, weight management, Zepbound Leave a comment
✔ VERIFIED EXPERT
Ravi Tiku – Professional Sales Expert
Ravi Tiku
Professional Sales Expert
38+ Years | Ex-NSM (Multinational Pharma)
🏅 Gold Medalist   |   📘 Author
🏢 Pharma Leadership
Real-world sales and strategy insights shaped by four decades of leadership.
📩 Join Ravi Tiku's Perspective
Loading
Those who aspire for sales-career.

🌤️ TODAY'S WEATHER
Gurugram, India
Loading today's weather...
☀️ °C
High: °C Low: °C

  • facebook
  • x
  • instagram
  • linkedin
  • pinterest
  • Home
  • About us
  • CALCULATOR
  • Contact
  • Disclaimer
  • Web stories
  • Privacy Policy
  • All-purpose Calculator
  • Get Expert Insights
  • Subscribe
© 2026 Ravi Tiku’s Perspective: Decoding Today’s Headlines • Built with GeneratePress